Diagnostic accuracy of the ovine CRH test in ACTH-dependent Cushing syndrome
Year: 2026
Type: article
Study design: Observational Study
Abstract: Determining the cause of adrenocorticotropin (ACTH)-dependent Cushing syndrome may require bilateral inferior petrosal sinus sampling (BIPSS). Ovine corticotropin-releasing hormone (oCRH) has been unavailable in the United States since 2020 and human CRH supply is constrained worldwide. We retrospectively reviewed 97 adults at one tertiary referral centre (1998-2018) who underwent oCRH stimulation as the peripheral component of BIPSS and in whom the sampling result was concordant with the final diagnosis: Cushing disease (CD; n = 87) or ectopic ACTH-dependent Cushing syndrome (EADCS; n = 10). Ten published threshold magnitudes and three exploratory in-sample thresholds were evaluated. The area under the curve was 0.854 (95% CI 0.681-0.986) for ACTH and 0.807 (0.593-0.953) for cortisol. All five published ACTH thresholds from ≥31% to ≥50% classified the primary cohort identically (sensitivity 95%, specificity 70%); an exploratory optimum of ≥73% gave 94% and 80%, with overlapping confidence intervals and the difference driven by one ectopic patient. Bootstrap resampling showed stable discrimination but marked threshold instability, with optimal cut-offs ranging from 18% to 80%. Adding two histologically confirmed ectopic patients with central BIPSS gradients reduced specificity at Δ73% to 75%. Applying published 30-minute criteria at 30 minutes modestly changed performance. Peak ACTH occurred by 30 minutes in 62% and by 60 minutes in all patients. These estimates apply to a BIPSS-referred population and do not support adoption of a new threshold.
Source: Endocrine Connections
DOI: 10.1530/ec-26-0473
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,146
OpenAlex ID: W7234115211
